Barbara Ascione Selected Research

Estrogen Receptor beta

2/2022

The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell Lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Ascione Research Topics

Disease

16	Neoplasms (Cancer) 04/2022 - 02/2005
5	Melanoma (Melanoma, Malignant) 04/2022 - 04/2002
3	Glioblastoma (Glioblastoma Multiforme) 11/2021 - 01/2018
2	Heart Failure 02/2022 - 01/2017
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2022
1	Papillomavirus Infections 01/2021
1	Mental Disorders (Mental Disorder) 01/2021
1	Glioma (Gliomas) 01/2021
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Lymphoma (Lymphomas) 01/2017
1	Infertility (Sterility) 01/2017
1	Hodgkin Disease (Hodgkin's Disease) 01/2017
1	Carcinogenesis 10/2013
1	Motor Disorders 12/2012
1	Gastroenteritis 12/2012
1	Human Influenza (Influenza) 12/2011
1	Neoplasm Metastasis (Metastasis) 08/2010
1	Endotoxemia 05/2010
1	Astrocytoma (Pilocytic Astrocytoma) 10/2009
1	Autoimmune Diseases (Autoimmune Disease) 02/2009
1	Kaposi Sarcoma (Kaposi's Sarcoma) 12/2007
1	Inflammation (Inflammations) 02/2005

Drug/Important Bio-Agent (IBA)

4	Biological ProductsIBA 01/2021 - 08/2010
4	Pharmaceutical PreparationsIBA 12/2019 - 12/2007
3	CathepsinsIBA 12/2011 - 04/2002
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 04/2022 - 01/2022
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2022 - 11/2019
2	Chlorpromazine (Thorazine)FDA Link 11/2021 - 01/2021
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 01/2018
2	Oncogene Proteins (Oncogene Protein)IBA 08/2016 - 10/2013
2	LipopolysaccharidesIBA 12/2012 - 05/2010
2	Peptide Hydrolases (Proteases)FDA Link 12/2011 - 08/2010
1	LuciferasesIBA 04/2022
1	Clonidine (ST 155)FDA LinkGeneric 04/2022
1	Antihypertensive Agents (Antihypertensives)IBA 04/2022
1	Estrogen Receptor betaIBA 02/2022
1	Silybin (Lagosa)IBA 02/2022
1	Epinephrine (Adrenaline)FDA LinkGeneric 01/2022
1	cirazolineIBA 01/2022
1	CatecholaminesIBA 01/2022
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022
1	LigandsIBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2021
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Actins (F Actin)IBA 12/2019
1	Antineoplastic Agents (Antineoplastics)IBA 12/2019
1	TubulinIBA 12/2019
1	Interleukin-8 (Interleukin 8)IBA 11/2019
1	Interleukin-6 (Interleukin 6)IBA 11/2019
1	CytokinesIBA 11/2019
1	Monoclonal AntibodiesIBA 01/2018
1	2,3-bis(4-hydroxyphenyl)-propionitrileIBA 01/2017
1	Estrogens (Estrogen)FDA Link 01/2017
1	NAD (NADH)IBA 01/2017
1	Estrogen ReceptorsIBA 01/2017
1	GelsolinIBA 08/2016
1	DNA (Deoxyribonucleic Acid)IBA 08/2016
1	AntioxidantsIBA 12/2012
1	pepstatin (pepstatin A)IBA 12/2011
1	Antiviral Agents (Antivirals)IBA 12/2011
1	N- (3- propylcarbamoyloxirane- 2- carbonyl)- isoleucyl- prolineIBA 08/2010
1	AntibodiesIBA 08/2010
1	Cathepsin BIBA 08/2010
1	Toll-Like Receptor 4IBA 05/2010
1	Interferon-gamma (Interferon, gamma)IBA 10/2009
1	ZymosanIBA 02/2009
1	Tyrosine Kinase InhibitorsIBA 12/2007
1	Imatinib Mesylate (Gleevec)FDA Link 12/2007
1	Fas Ligand Protein (Fas Ligand)IBA 02/2005
1	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 02/2005
1	InterferonsIBA 04/2002
1	StaurosporineIBA 04/2002
1	Interferon Type IIBA 04/2002
1	CaspasesIBA 04/2002
1	Cisplatin (Platino)FDA LinkGeneric 04/2002

Therapy/Procedure

6	Therapeutics 04/2022 - 04/2016
1	Drug Therapy (Chemotherapy) 01/2018
1	Radiotherapy 01/2017
1	Ligation 01/2017